US Stock MarketDetailed Quotes
MTRYW MONTEREY BIO ACQUISITION CORP C/WTS 30/09/2026 (TO PUR COM)
- 0.0003
- 0.00000.00%
Close Nov 20 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0003Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.055052wk High0.00P/B0Float Cap0.000352wk Low--Dividend TTM0Shs Float0.5500Historical High--Div YieldTTM0.00%Amplitude0.0003Historical Low--Avg Price1Lot Size
MONTEREY BIO ACQUISITION CORP C/WTS 30/09/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 6.64%365.61K | -8.13%339.09K | 289.95%2.04M | -11.38%463.21K | 474,554.40%863.87K | 1,371,228.00%342.83K | 369.09K | 522.88K | 522.68K | 182 |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | 474,554.40%863.87K | ---- | ---- | ---- | ---- | --182 |
| -General and administrative expense | ---- | ---- | ---- | ---- | 474,554.40%863.87K | ---- | ---- | ---- | ---- | --182 |
| Other operating expenses | 6.64%365.61K | -8.13%339.09K | 289.95%2.04M | ---- | ---- | --342.83K | --369.09K | --522.88K | ---- | ---- |
| Operating profit | -6.64%-365.61K | 8.13%-339.09K | -289.95%-2.04M | 11.38%-463.21K | -474,554.40%-863.87K | -1,371,228.00%-342.83K | -369.09K | -522.88K | -522.68K | -182 |
| Net non-operating interest income expense | 64.74%258.39K | 1,819.35%224.49K | 37,061.20%881.09K | 7,842.98%188.33K | 524.22K | 156.85K | 11.7K | 2.37K | 2.37K | 0 |
| Non-operating interest income | 64.74%258.39K | 1,819.35%224.49K | 37,061.20%881.09K | 7,842.98%188.33K | --524.22K | --156.85K | --11.7K | --2.37K | --2.37K | --0 |
| Other net income (expense) | -62.72K | |||||||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---62.72K | ---- | ---- |
| Income before tax | 42.35%-107.21K | 67.93%-114.61K | -98.54%-1.16M | 52.85%-274.88K | -186,519.78%-339.65K | -743,848.00%-185.99K | -357.4K | -583.23K | -583.02K | -182 |
| Income tax | 1,437.86%44.28K | 37.65K | 115.96K | 32.24K | 80.84K | 2.88K | 0 | 0 | 0 | 0 |
| Net income | 19.79%-151.49K | 57.40%-152.26K | -118.42%-1.27M | 47.32%-307.12K | -230,939.01%-420.49K | -755,364.00%-188.87K | -357.4K | -583.23K | -583.02K | -182 |
| Net income continuous Operations | 19.79%-151.49K | 57.40%-152.26K | -118.42%-1.27M | 47.32%-307.12K | -230,939.01%-420.49K | -755,364.00%-188.87K | ---357.4K | ---583.23K | ---583.02K | ---182 |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.79%-151.49K | 57.40%-152.26K | -118.42%-1.27M | 47.32%-307.12K | -230,939.01%-420.49K | -755,364.00%-188.87K | -357.4K | -583.23K | -583.02K | -182 |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.79%-151.49K | 57.40%-152.26K | -118.42%-1.27M | 47.32%-307.12K | -230,939.01%-420.49K | -755,364.00%-188.87K | -357.4K | -583.23K | -583.02K | -182 |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg